Rockwell Medical Announces Dosing of First Patient in Pivotal Triferic® Phase 3 Trial by Partner, Wanbang Biopharmaceuticals, in China
13 janv. 2021 07h00 HE
|
Rockwell Medical, Inc.
WIXOM, Mich., Jan. 13, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and iron deficiency...
Rockwell Medical, Inc. to Present at H.C. Wainwright BioConnect 2021 Conference
05 janv. 2021 07h00 HE
|
Rockwell Medical, Inc.
WIXOM, Mich., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming the treatment of...
Industry Veteran Andrea Heslin Smiley joins Rockwell Medical’s Board of Directors
16 déc. 2020 07h00 HE
|
Rockwell Medical, Inc.
WIXOM, Mich., Dec. 16, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming the treatment of...
Rockwell Medical, Inc. Provides Third Quarter 2020 Financial and Operational Update
09 nov. 2020 16h05 HE
|
Rockwell Medical, Inc.
-Ended the quarter with $67.3 million in cash, cash equivalents and investments- -Q3 2020 revenue of $15.3 million- -U.S. commercial launch of Triferic® AVNU expected in Q1 2021- -Poised to enroll...
Rockwell Medical to Report Third Quarter 2020 Financial and Operating Results on November 9, 2020
27 oct. 2020 08h00 HE
|
Rockwell Medical, Inc.
WIXOM, Mich., Oct. 27, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI) ("Rockwell Medical" or the “Company”), a biopharmaceutical company dedicated to transforming the treatment of...
Rockwell Medical, Inc. Announces Presentations at the American Society of Nephrology Virtual Kidney Week 2020
13 oct. 2020 08h00 HE
|
Rockwell Medical, Inc.
WIXOM, Mich., Oct. 13, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming the treatment of...
Rockwell Medical Announces Growth Plan and New Therapeutic Opportunities for Its Ferric Pyrophosphate Citrate (FPC) Platform
24 sept. 2020 18h09 HE
|
Rockwell Medical, Inc.
-New indications for FPC platform provide significant growth opportunity- -Anticipates Type C meeting with FDA for home infusion in Q1 2021 and for acute heart failure in 2H 2021- ...
Rockwell Medical Announces $35.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
23 sept. 2020 08h45 HE
|
Rockwell Medical, Inc.
WIXOM, Mich., Sept. 23, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming the treatment of...
Rockwell Medical Announces Appointment of Russell L. Skibsted as Executive Vice President, Chief Financial Officer and Chief Business Officer
15 sept. 2020 07h59 HE
|
Rockwell Medical, Inc.
WIXOM, Mich., Sept. 15, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming the treatment of...
Rockwell Medical Enters into Exclusive License Agreement with Jeil Pharmaceutical Co., Ltd., for the Rights to Commercialize Triferic® in South Korea
09 sept. 2020 16h15 HE
|
Rockwell Medical, Inc.
WIXOM, Mich., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming the treatment of...